Stock Price Quote

FISCHER MEDICAL VENTURES LTD.

NSE : FISCHERBSE : 524743ISIN CODE : INE771F01025Industry : ChemicalsHouse : Private
BSE843.0566.1 (+8.51 %)
PREV CLOSE ( ) 776.95
OPEN PRICE ( ) 796.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 15130
TODAY'S LOW / HIGH ( )783.00 861.65
52 WK LOW / HIGH ( )573.6 919
NSE845.0569.2 (+8.92 %)
PREV CLOSE( ) 775.85
OPEN PRICE ( ) 804.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 845.05 (5)
VOLUME 105711
TODAY'S LOW / HIGH( ) 782.55 859.00
52 WK LOW / HIGH ( )770.1 839.9
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1993
Management Info
Ravindran Govindan - Chairman Ravindran Govindan - Managing Director
Registered Office

Address Survey No. 480/2 A P Medtech Zone,Nadupura Village,Pedagantyadu Mandal,
Vijayawada,
Andhra Pradesh-530032

Phone 08655550209

Email enquiry@fischermv.com

Website www.fischermv.com

Registrars Details
Adroit Corporate Services Pvt Ltd
17-20 Jaferbhoy Industrial Estate , 1st Floor,Makwana Road,Marol Naka,Mumbai
Listing : BSE, NSE

NEWS

11Jul Fischer Medical Ventures partners with
Fischer Medical Ventures has partnered with the City of Jember, Indonesi..
11Jul Fischer Medical Ventures zooms on part
Fischer Medical Ventures is currently trading at Rs. 851.20, up by 74.25..
10Jul Fischer Medical Ventures acquires land
Fischer Medical Ventures (FMV) has successfully acquired a landmark mixe..
22Apr Fischer Medical Ventures’ arm gets nod
Fischer Medical Ventures’ Material Subsidiary -- Time Medical Internatio..
22Apr Fischer Medical Ventures jumps as its
Fischer Medical Ventures is currently trading at Rs. 815.85, up by 15.05..

Financials

in Millions
QTR Mar 25 ANNUAL 25
Net Profit-8.926.63
Gross Profit -11.32 9.61
Operating Profit -9.0912.2
Net Sales 52.252.2

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Elantas Beck India (BSE)
peergroup  13791.10 (11.39%)
M.Cap ( in Cr)10315.14
Navin Fluorine Intl (BSE)
peergroup  5072.60 (1.31%)
M.Cap ( in Cr)24694.71
Keltech Energies (BSE)
peergroup  4106.40 (1.11%)
M.Cap ( in Cr)406.72
Nitta Gelatin India (BSE)
peergroup  993.75 (3.31%)
M.Cap ( in Cr)896.11
Hardcastle&Waud Mfg (BSE)
peergroup  731.95 (3.14%)
M.Cap ( in Cr)50.07

Shareholding Pattern

PROMOTERS 61.8%
NON-INSTITUTION 31.23%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Fischer Medical Ventures Ltd.

Fischer Medical Ventures Ltd. was incorporated in the year 1993. Its today's share price is 843.05. Its current market capitalisation stands at Rs 5390.14 Cr. In the latest quarter, company has reported Gross Sales of Rs. 115.28 Cr and Total Income of Rs.122.79 Cr. The company's management includes Aarati Sachin Khare, Aravindkumar V, Sanjay Jayantilal Jain, Roberto M Pagdanganan, Jacob Thomas, Khairy Jamaluddin Abu Bakar, Svetlana Rao Raviwada, Ravindran Govindan, Ravindran Govindan.

It is listed on the BSE with a BSE Code of 524743 , NSE with an NSE Symbol of FISCHER and ISIN of INE771F01025. It's Registered office is at Survey No. 480/2 A P Medtech Zone,Nadupura Village,Pedagantyadu MandalVijayawada-530032, Andhra Pradesh. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Ashvin Thumar & Co, Bilimoria Mehta & Co, Koshal & Associates, Koshal & Associates, Vivekanandan Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.